Esperion Therap (ESPR) Posts Q1 Loss of 51c/Share
Tweet
Share
E-mailGet Alerts ESPR Hot Sheet
Join SI Premium – FREE
Esperion Therap (NASDAQ: ESPR) reported Q1 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Esperion Therap (ESPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Electronics (BHE) Tops Q2 EPS by 16c; offers guidance
- Dynegy (DYN) Misses Q2 EPS by 33c
- National Fuel Gas (NFG) Tops Q3 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
